1H'25 vs. 1H'24 Results Sales: € 2.299 Bn (+5.9% vs. +6.2% BS(e) and +6.3% consensus); Adjusted EBITDA: € 445.4 M (+8.6% vs. +6.5% BS(e) and +6.7% consensus); Adjusted EBIT: € 332.31 M (+6.2% vs. +5.0% BS(e) and +5.5% consensus); Adjusted Net Profit: € 247.3 M (+3.9% vs. +10.2% BS(e) and n.a. consensus);
NEWS SUMMARY: CHANGES IBEX, INDITEX, PUIG BRANDS, SANTANDER. IBEX holds on above 15,000 It was a session of little movement and few macro references on European stock markets after the fall of the French Govt. was confirmed. In the STOXX 600, the best-performing sectors were Basic Materials and Energy, with Autos and Construction falling the most. On the macro side, in the US, August’s SME confidence (NFIB) rose more than expected to its highest level since January. The preliminary annual revie...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: INDITEX, SANTANDER, PUIG. El Ibex aguanta en los 15.000 puntos Jornada de poco movimiento y escasas referencias macro significativas en las bolsas europeas, una vez confirmada la caída del Gobierno en Francia. En el STOXX 600 los mejores sectores fueron R. Básicos y Energía frente a Autos y Construcción que fueron los que más cayeron. Por el lado macro, en EE.UU. la confianza de las PyMes NFIB de agosto repuntó más de lo esperado hasta el nivel más...
A director at Sacyr S.A. sold 302,864 shares at 3.670EUR and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Rdos. 2T'25 vs 2T'24: Ventas: 1.178 M euros (+4,7% vs +3,6% BS(e) y +0,7% consenso); EBITDA: 346,0 M euros (+8,9% vs +3,6% BS(e) y +1,3% consenso); EBIT: 221,65 M euros (-28,3% vs -33,1% BS(e) y -34,4% consenso); BDI: 3,52 M euros (-86,8% vs -13,25 M euros BS(e) y -6,0 M euros consenso); Rdos. 1S'25 vs 1S'24: Ventas: 2.237 M euros (+5,6% vs +5,0% BS(e) y +3,4% consenso); EBITDA: 647,0 M euros (-1,5% vs -4,1% BS(e) y -5,2% consenso); EBIT: 463,89 M euros (-22,6% vs -25,1% BS(e) y -25,7% consenso)...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.